25 results
8-K
EX-99.1
RLYB
Rallybio Corp
6 Feb 24
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
8:15am
us on a path toward long-term success," said Stephen Uden, M.D. Chief Executive Officer of Rallybio.
“I would like to personally thank our departing
8-K
EX-1.1
lx3ti
14 Nov 22
Entry into a Material Definitive Agreement
4:12pm
S-3
EX-1.2
w7zri
8 Aug 22
Shelf registration
5:23pm
DEF 14A
c7jnq
25 Apr 22
Definitive proxy
5:03pm
10-K
2ibtub0qkd fsz
15 Mar 22
Annual report
4:31pm
10-Q
dna7ui8
9 Sep 21
Quarterly report
4:16pm
424B4
icxcd7d5l8wqkju37lh
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
EX-10.19
x7ljp2
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
9xrq c54urqxdwpei
22 Jul 21
IPO registration (amended)
4:04pm